7. GLP-1s, Compliance & Clinical Strategy: Expert Advice for 2026 Success with David Caddell

GLP-1s are driving explosive growth in cash-pay clinics - but they’re also creating serious legal exposure for the unprepared. In this episode, Alex Sidorenkov sits down with David Caddell, President of EC3Health, to unpack the compliance must-knows every clinic needs before promoting semaglutide or tirzepatide.What’s legal, what’s risky, and how to choose a compounding pharmacyHow to structure your GLP-1 offering for long-term revenueWhy HRT and peptide therapy should follow GLP-1s in the patient journeyIf you’re selling semaglutide or tirzepatide or planning to - don’t miss this. It could protect your business and position you for long-term growth. _____This episode of The Wellness Practice Playbook is also available for streaming on our website, YouTube, Apple Podcast, and Spotify.